People · Operator
Named in public records as an officer, director or promoter · active 2017–2025 · Other Technology, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Chowbus, Inc. | — | Other Technology | Series C | $173.0M | $322.3M | 2017 |
| Enrich Biosystems Inc. | — | Biotechnology | Seed | $8.2M | $3.3M | 2022 |
Qi Zhao at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Qi Zhao on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Daniel Wagner | 1 | 13 |
| Harley Miller | 1 | 9 |
| Eddie Lou | 1 | 6 |
| Matthew Roberts | 1 | 4 |
| Christopher McLeod | 1 | 3 |
| Jay Teich | 1 | 2 |
| Gajin Tsai | 1 | 2 |
| Mark Lawrence | 1 | 2 |
| Kenny Tsai | 1 | 1 |
| Dong Wang | 1 | 1 |
| Cynthia Green | 1 | 1 |
| Linxin Wen | 1 | 1 |
| Suyu Zhang | 1 | 1 |
| Raphi Savitz | 1 | 1 |
| Yining Wei | 1 | 1 |
| Jonathan Fan | 1 | 1 |
| Howard Bhyun | 1 | 1 |
| Pu Chen | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.